Daniel Klain's Contact Details

Daniel Klain's Company Details

BioView

Billerica, MA, US • 20 - 49 Employees
Medical Equipment

Our Mission is to improve cancer patient's assessments and outcomes. BioView develops, manufactures, and markets innovative Automated cell imaging and analysis platforms for use in cytology, cytogenetics and pathology at clinical and research laboratories who wish to digitize and streamline their analysis workflow. BioView's industry-leading platforms offer advanced capabilities for Fluorescent and Bright-field based applications driven by Artificial intelligence. Starting from automated FISH Analysis of tissue and cells suspension for cancer and genetic abnormalities, to automated whole slide imaging for digital pathology and quantitative IHC scoring application for nuclear & membrane staining.Bringing liquid Biopsy to the clinical PracticeWe are a world leader in providing solutions for Circulating tumor cells detection, enumeration and characterization. Our all-in-one DeNovo system, offers high levels of speed, standardization and sensitivity. It is easy to operate, and can be integrated with any CTC enrichment method, as well as any combination of immunofluorescence and FISH markers.NGK – New Generation KaryotypingAn innovative platform powered by deep learning dramatically enhances technician efficiency and productivity and introduces first of a kind supervisor monitoring tools and an ISCN results generator that is directly linked to an online supporting cytogenetics database.Our customers leverage offline analysis and Web-based applications to collaborate with their colleagues and explore new business opportunities.